Join Dr. Weaver for this year’s Research Forum webinar to hear him clear up common misconceptions about dementia and explore the clinical and research evidence behind them. This is your chance to ask an expert any questions, live and for free!
Get your facts checked! Every day we come across information, “breaking news” or new developments about the cause, diagnosis, progression and treatment of dementia. But how do we know if they’re facts, misconceptions or myths? What’s the research behind them?
Dr. Donald Weaver is a Senior Scientist at the Krembil Brain Institute (University Health Network, Toronto) and Professor of Medicine (Neurology) and Chemistry at the University of Toronto, where he also holds the Krembil Chair in Drug Discovery for Alzheimer’s Disease. He obtained his MD and PhD from Queen’s University and has been a Professor of Neurology and Chemistry at Queen’s University (1989-2001), Dalhousie University (2001-2013) and the University of Toronto (2013 – present). He cofounded multiple biotech companies and is currently Chief Medical Officer of Treventis Corp. He published more than 350 papers on drug design for neurological diseases and holds 47 patents on drug discoveries. Two of Dr. Weaver’s compounds reached Phase III human clinical trials. His current research is focused on the role of neuroinflammation in Alzheimer’s disease.
If you have any questions, please contact Jennifer Licardo
at alzeducation@alzheimer.mb.ca or 204-943-6622.